Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 593 - 600 of 12142 results

Insurance Industry Key in Net-Zero Transition, UN Group Says
November 14, 2024| News

Best Practices in Developing Winning IP Strategies for AI Companies
November 14, 2024| Article| Viewpoint

AI Under a Second Trump Administration — AI: The Washington Report
November 14, 2024| Article| Viewpoint

Fertility Related Loss To Be Covered Under the Massachusetts Earned Sick Time Act
November 13, 2024| Blog| Viewpoint

Trump EPA Pick Seen Supporting PFAS Limits, Revising Water Rules
November 13, 2024| News

First CRISPR-Cas9 Drug Monetised in Spate of Big-Money Royalty Transactions
November 12, 2024| News

Trump's Selection of Zeldin to Head EPA Draws Surprise, Little Hope of Avoiding Deregulation
November 12, 2024| News

The Federal Circuit Swings the Door to Anti-Suit Injunctions Back Open
November 8, 2024| Blog| Viewpoint
News & Press Releases
Mintz Advises Point72 and Tsunami Express Car Wash in Acquisition of 53 Car Wash Locations from Whistle Express Car Wash
September 16, 2025
Mintz advised Point72 and Tsunami Express Car Wash, its portfolio company, in Tsunami’s acquisition of 53 car wash locations from Whistle Express Car Wash, which is owned by affiliates of Oaktree Capital Management.
Mintz Advises Charlesbank Capital Partners on Acquisition of Q6 Cyber
September 15, 2025
Mintz Advises on LB Pharmaceuticals’ $285 Million Initial Public Offering
September 12, 2025
Mintz advised the underwriters in connection with a $285 million initial public offering by LB Pharmaceuticals Inc of 19,000,000 shares of common stock at an initial public offering price of $15.00 per share. The aggregate gross proceeds to LB Pharmaceuticals from this offering were approximately $285 million before deducting underwriting discounts and commissions and other offering expenses. In addition, LB Pharmaceuticals granted the underwriters a 30-day option to purchase up to an additional 2,850,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The shares began trading on the Nasdaq Global Market on September 11, 2025 under the ticker symbol “LBRX.”
Events
Podcasts

Mintz On Air: Practical Policies – DEI Developments: The Proxy Problem
September 16, 2025| Podcast|

Mintz On Air: Practical Policies – Disparage Me Not
August 26, 2025| Podcast|

Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|
